株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

核医学 - 世界市場の見通し(2017年~2026年)

Nuclear Medicine - Global Market Outlook (2017-2026)

発行 Stratistics Market Research Consulting 商品コード 744597
出版日 ページ情報 英文 168 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.87円で換算しております。
Back to Top
核医学 - 世界市場の見通し(2017年~2026年) Nuclear Medicine - Global Market Outlook (2017-2026)
出版日: 2018年10月01日 ページ情報: 英文 168 Pages
概要

世界の核医学市場は、2017年に35億米ドルと評価され、2017年から2025年にかけては7.1%のCAGRで推移し、2026年までに65億米ドル規模の市場に成長することが予測されています。早期診断・精密診断に対する需要の増加、がんおよび心血管疾患の罹患率の上昇、CTやPETなどの医療イメージングの需要の増加などによって当市場の成長が促進される見通しです。

当レポートでは、世界の核医学市場を調査し、市場の概要、製品・用途・エンドユーザー・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 市場動向の分析

  • イントロダクション
  • 成長要因
  • 阻害要因
  • 市場機会
  • 脅威
  • 製品分析
  • 用途分析
  • エンドユーザー分析
  • 新興市場
  • 市場のシナリオ

第4章 ファイブフォース分析

  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係

第5章 核医学市場の分析と予測:製品別

  • イントロダクション
  • 治療
    • 近接照射療法
    • ベータ放射体
    • アルファ放射体
  • 診断
    • PET
    • SPECT

第6章 核医学市場の分析と予測:用途別

  • イントロダクション
  • 治療
    • 内分泌腫瘍
    • リンパ腫
    • 骨転移
    • 甲状腺
    • その他
  • 診断
    • 甲状腺
    • 神経
    • リンパ腫
    • 心臓
    • 腫瘍
    • その他

第7章 核医学市場の分析と予測:エンドユーザー別

  • イントロダクション
  • 研究機関
  • 病院・診断センター

第8章 核医学市場の分析と予測:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他

第9章 主な市場動向

  • 合意、パートナーシップ、コラボレーション、合弁事業
  • 買収・合併
  • 新製品の発売
  • 事業拡張
  • その他

第10章 企業プロファイル

  • Bayer AG
  • Medtronic, plc
  • General Electric Co.
  • Cardinal Health, Inc.
  • IBA Group
  • BWX Technologies
  • Australian Nuclear Science & Technology Organization (ANSTO)
  • Mallinckrodt plc.
  • Eckert & Ziegler Group
  • Lantheus Medical Imaging, Inc.
  • Jubilant Life Sciences
  • Eczacibasi-Monrol Nuclear Products
  • Curium
  • Bracco Imaging S.p.A
  • NTP Radioisotopes SOC Ltd.
図表

List of Tables

  • Table 1 Global Nuclear Medicine Market Outlook, By Region (2016-2026) (US $MN)
  • Table 2 Global Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)
  • Table 3 Global Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 4 Global Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)
  • Table 5 Global Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)
  • Table 6 Global Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)
  • Table 7 Global Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 8 Global Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)
  • Table 9 Global Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)
  • Table 10 Global Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)
  • Table 11 Global Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 12 Global Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)
  • Table 13 Global Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 14 Global Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)
  • Table 15 Global Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 16 Global Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)
  • Table 17 Global Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 18 Global Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 19 Global Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 20 Global Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 21 Global Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)
  • Table 22 Global Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 23 Global Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)
  • Table 24 Global Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)
  • Table 25 Global Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)
  • Table 26 Global Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)
  • Table 27 North America Nuclear Medicine Market Outlook, By Country (2016-2026) (US $MN)
  • Table 28 North America Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)
  • Table 29 North America Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 30 North America Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)
  • Table 31 North America Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)
  • Table 32 North America Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)
  • Table 33 North America Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 34 North America Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)
  • Table 35 North America Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)
  • Table 36 North America Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)
  • Table 37 North America Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 38 North America Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)
  • Table 39 North America Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 40 North America Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)
  • Table 41 North America Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 42 North America Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)
  • Table 43 North America Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 44 North America Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 45 North America Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 46 North America Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 47 North America Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)
  • Table 48 North America Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 49 North America Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)
  • Table 50 North America Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)
  • Table 51 North America Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)
  • Table 52 North America Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)
  • Table 53 Europe Nuclear Medicine Market Outlook, By Country (2016-2026) (US $MN)
  • Table 54 Europe Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)
  • Table 55 Europe Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 56 Europe Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)
  • Table 57 Europe Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)
  • Table 58 Europe Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)
  • Table 59 Europe Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 60 Europe Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)
  • Table 61 Europe Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)
  • Table 62 Europe Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)
  • Table 63 Europe Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 64 Europe Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)
  • Table 65 Europe Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 66 Europe Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)
  • Table 67 Europe Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 68 Europe Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)
  • Table 69 Europe Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 70 Europe Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 71 Europe Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 72 Europe Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 73 Europe Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)
  • Table 74 Europe Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 75 Europe Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)
  • Table 76 Europe Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)
  • Table 77 Europe Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)
  • Table 78 Europe Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)
  • Table 79 Asia Pacific Nuclear Medicine Market Outlook, By Country (2016-2026) (US $MN)
  • Table 80 Asia Pacific Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)
  • Table 81 Asia Pacific Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 82 Asia Pacific Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)
  • Table 83 Asia Pacific Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)
  • Table 84 Asia Pacific Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)
  • Table 85 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 86 Asia Pacific Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)
  • Table 87 Asia Pacific Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)
  • Table 88 Asia Pacific Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)
  • Table 89 Asia Pacific Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 90 Asia Pacific Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)
  • Table 91 Asia Pacific Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 92 Asia Pacific Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)
  • Table 93 Asia Pacific Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 94 Asia Pacific Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)
  • Table 95 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 96 Asia Pacific Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 97 Asia Pacific Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 98 Asia Pacific Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 99 Asia Pacific Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)
  • Table 100 Asia Pacific Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 101 Asia Pacific Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)
  • Table 102 Asia Pacific Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)
  • Table 103 Asia Pacific Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)
  • Table 104 Asia Pacific Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)
  • Table 105 South America Nuclear Medicine Market Outlook, By Country (2016-2026) (US $MN)
  • Table 106 South America Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)
  • Table 107 South America Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 108 South America Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)
  • Table 109 South America Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)
  • Table 110 South America Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)
  • Table 111 South America Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 112 South America Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)
  • Table 113 South America Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)
  • Table 114 South America Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)
  • Table 115 South America Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 116 South America Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)
  • Table 117 South America Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 118 South America Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)
  • Table 119 South America Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 120 South America Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)
  • Table 121 South America Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 122 South America Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 123 South America Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 124 South America Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 125 South America Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)
  • Table 126 South America Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 127 South America Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)
  • Table 128 South America Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)
  • Table 129 South America Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)
  • Table 130 South America Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)
  • Table 131 Middle East & Africa Nuclear Medicine Market Outlook, By Country (2016-2026) (US $MN)
  • Table 132 Middle East & Africa Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)
  • Table 133 Middle East & Africa Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 134 Middle East & Africa Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)
  • Table 135 Middle East & Africa Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)
  • Table 136 Middle East & Africa Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)
  • Table 137 Middle East & Africa Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 138 Middle East & Africa Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)
  • Table 139 Middle East & Africa Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)
  • Table 140 Middle East & Africa Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)
  • Table 141 Middle East & Africa Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)
  • Table 142 Middle East & Africa Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)
  • Table 143 Middle East & Africa Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 144 Middle East & Africa Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)
  • Table 145 Middle East & Africa Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 146 Middle East & Africa Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)
  • Table 147 Middle East & Africa Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)
  • Table 148 Middle East & Africa Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)
  • Table 149 Middle East & Africa Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 150 Middle East & Africa Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)
  • Table 151 Middle East & Africa Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)
  • Table 152 Middle East & Africa Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 153 Middle East & Africa Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)
  • Table 154 Middle East & Africa Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)
  • Table 155 Middle East & Africa Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)
  • Table 156 Middle East & Africa Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)
目次

According to Stratistics MRC, the Global Nuclear Medicine is accounted for $3.50 billion in 2017 and is expected to reach $6.50 billion by 2026 growing at a CAGR of 7.1% during the forecast period. Factors such as growing demand for early & precise diagnostic methods, increasing incidence of cancer and cardiovascular disorders and huge demand for single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging are driving the market growth. However, supply deficiency, reimbursement hurdles for the manufacturer and high capital investment are restricting the growth of the growth. Moreover, rising economies, upcoming radioisotopes and increasing usage across neurological applications are providing ample opportunities for the market growth.

Nuclear medicines are used for both diagnostic and therapeutic uses and there are more than 30 specific radiopharmaceuticals used by medical practitioners. Nuclear medicine comes under the field of molecular imaging, which occupy the use of very little amount of radioactive material to detect and treat disease Several forms of nuclear medicines are required in treating cancer, neurological disorders, gastrointestinal and other diseases.

On the basis of application, therapeutic segment witnessed steady growth due to the introduction of advanced protective measures and growing awareness regarding the therapeutic procedures. By geography, North America is dominating the market during the forecasting period owing to increasing aging population, technological advancements and the presence of favorable reimbursement policies in this region.

Some of the key players in the Nuclear Medicine Market include Bayer AG, Medtronic, plc, General Electric Co., Cardinal Health, Inc., IBA Group, BWX Technologies, Australian Nuclear Science & Technology Organization (ANSTO), Mallinckrodt plc., Eckert & Ziegler Group, Lantheus Medical Imaging, Inc., Jubilant Life Sciences, Eczacibasi-Monrol Nuclear Products, Curium, Bracco Imaging S.p.A and NTP Radioisotopes SOC Ltd.

Products Covered:

  • Therapeutic
  • Diagnostic

Applications Covered:

  • Therapeutic Applications
  • Diagnostic Applications

End Users Covered:

  • Research institutes
  • Hospitals and Diagnostic centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nuclear Medicine Market, By Product

  • 5.1 Introduction
  • 5.2 Therapeutic
    • 5.2.1 Brachytherapy
      • 5.2.1.1 Iodine-125
      • 5.2.1.2 Iridium-192
      • 5.2.1.3 Cesium-131
      • 5.2.1.4 Palladium-103
      • 5.2.1.5 Other Brachytherapies
    • 5.2.2 Beta emitters
      • 5.2.2.1 Lu-117
      • 5.2.2.2 Iodine-131
      • 5.2.2.3 Samarium-153
      • 5.2.2.4 Yttrium-90
      • 5.2.2.5 Rhenium 186/188
      • 5.2.2.6 Strontium 89
      • 5.2.2.7 Other beta emitters
    • 5.2.3 Alpha emitters
      • 5.2.3.1 RA-223
      • 5.2.3.2 Other alpha emitters
  • 5.3 Diagnostic
    • 5.3.1 Positron Emission Tomography (PET)
      • 5.3.1.1 RB-82
      • 5.3.1.2 F-18
      • 5.3.1.3 Other PET products
    • 5.3.2 Single Photon Emission Computed Tomography (SPECT)
      • 5.3.2.1 TL-201
      • 5.3.2.2 TC-99m
      • 5.3.2.3 GA-67
      • 5.3.2.4 Other SPECT products

6 Global Nuclear Medicine Market, By Application

  • 6.1 Introduction
  • 6.2 Therapeutic
    • 6.2.1 Endocrine Tumors
    • 6.2.2 Lymphoma
    • 6.2.3 Bone Metastasis
    • 6.2.4 Thyroid
    • 6.2.5 Other Therapeutic Applications
  • 6.3 Diagnostic
    • 6.3.1 Thyroid
    • 6.3.2 Neurology
    • 6.3.3 Lymphoma
    • 6.3.4 Cardiology
    • 6.3.5 Oncology
    • 6.3.6 Other Diagnostics

7 Global Nuclear Medicine Market, By End User

  • 7.1 Introduction
  • 7.2 Research institutes
  • 7.3 Hospitals and diagnostic centers

8 Global Nuclear Medicine Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Bayer AG
  • 10.2 Medtronic, plc
  • 10.3 General Electric Co.
  • 10.4 Cardinal Health, Inc.
  • 10.5 IBA Group
  • 10.6 BWX Technologies
  • 10.7 Australian Nuclear Science & Technology Organization (ANSTO)
  • 10.8 Mallinckrodt plc.
  • 10.9 Eckert & Ziegler Group
  • 10.10 Lantheus Medical Imaging, Inc.
  • 10.11 Jubilant Life Sciences
  • 10.12 Eczacibasi-Monrol Nuclear Products
  • 10.13 Curium
  • 10.14 Bracco Imaging S.p.A
  • 10.15 NTP Radioisotopes SOC Ltd.
Back to Top